Skip to content
DataLookout
Menu

PBM in iAMDNCT07554690

Photobiomodulation Laser for Reticular Pseudodrusen in Age-Related Macular Degeneration

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 4 more changesShow less
    • Eligibility criteria expanded, about 20 words
    • Start date changed from estimate of Oct 2026 to Oct 9, 2026
    • Secondary endpoints: details revised at 2 of 9 entries
    • Site details revised
  2. Notable Start date: Jun 1, 2026 to Oct 2026v3
  3. Minor Secondary endpoints: 5 to 9v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Change in Low-Luminance Visual Acuity (LLVA)
Timeframe: Baseline to Month 12

Secondary (9)

Change in Low-Luminance Contrast Sensitivity (LLCS)
Change in Retinal Sensitivity Measured by Microperimetry
Change in Retinal Structure Assessed by Optical Coherence Tomography (SD-OCT)
Change in Fundus Autofluorescence Patterns
Progression to Advanced Age-Related Macular Degeneration
Show 4 moreShow less
Change in Retinal Perfusion Density Assessed by OCT Angiography
Change in Vessel Length Density Assessed by OCT Angiography
Change in Foveal Avascular Zone Area Assessed by OCT Angiography
Change in Choriocapillaris Flow Deficit Assessed by OCT Angiography

Arms and interventions

Photobiomodulation (PBM) Laser TreatmentExperimental

Participants assigned to this arm will receive photobiomodulation (PBM) therapy using a CE-marked medical device. Treatment is delivered in two cycles: the first cycle consists of 8 sessions over 4 weeks (two sessions per week), and the second cycle consists of 6 sessions over 3 weeks. Each session lasts approximately 12 minutes and includes exposure to specific wavelengths of light under standardized conditions.

Sham TreatmentPlacebo comparator

Participants assigned to this arm will undergo sham treatment following the same schedule and procedures as the active treatment group, including identical session frequency and duration. The device delivers minimal, non-therapeutic light energy, ensuring no active photobiomodulation effect while maintaining masking conditions.

Procedures: Photobiomodulation Therapy, Sham Photobiomodulation

Sites

1 site in 1 country

  • IRCCS Fondazione G.B.Bietti c/o Ospedale BritannicoRoma, Italy, Italy